Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) Stock

SHPMY

Shanghai Pharmaceuticals Holding Co., Ltd SHPMY · OTC

$6.45 -9.03% (-$0.64)

Market cap: ¥31.9B
Enterprise value: ¥49.1B
P/E: 6.2x
Forward P/E: -
PEG: 0.2x
P/S: 0.1x
P/FCF: 4.6x
EV/EBITDA: 4.5x
ROIC: 4.3%
Gross margin: 10.6%
Net margin: 1.8%
Dividend yield: 5.14%
Payout ratio: 31.7%
Net debt/EBITDA: 1.6x
Beta: 0.16
Free float: 28.6%

Return vs S&P 500

Period	SHPMY	S&P 500	Difference
1 month	+0.1%	-2.0%	+2.1 pp
3 months	+0.7%	-2.2%	+2.9 pp
Year to date	-13.9%	+10.6%	-24.4 pp
1 year	-13.9%	+11.8%	-25.6 pp
3 years	+0.3%	+73.7%	-73.4 pp
5 years	-20.9%	+61.7%	-82.6 pp
10 years	-46.8%	+263.0%	-309.8 pp

Price change, dividends not included.

About the company

Shanghai Pharmaceuticals Holdings is a Chinese company focused on pharmaceuticals and healthcare. Founded in 1994, it is one of the leading players in the Chinese pharmaceutical market. The company specializes in the development, manufacturing, and distribution of medicines, medical devices, and other healthcare products. Shanghai Pharmaceuticals is involved in pharmaceutical research and development and also focuses on the production of generic drugs and ensuring access to innovative therapies for the general public. The company operates not only in China but also in international markets and collaborates with global healthcare partners.

Sector

Healthcare

Industry

Medical - Distribution

CEO

Qiuhua Yang

Employees

49,608

Headquarters

Shanghai

Valuation

Is today's price reasonable?

What speaks for it: The share price is below the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

What speaks for it: It has been profitable 6 years in a row.
What to watch: Out of every 100 CNY of revenue, only 1.8 CNY is left as net profit.
What to watch: It earns only 4.3 CNY a year on every 100 CNY of invested capital.

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number